News Posts List
Researchers Receive Grants from NCCN Oncology Research Program
10/16/2012
The NCCN Oncology Research Program (ORP) announces funding of five new investigator-initiated studies of tivozanib as a result of funding through the AVEO/Astellas collaboration.
Argos Therapeutics Identifies Immune Response Marker Connected to Prolonged Overall Survival in mRCC Patients Treated With AGS-003
10/15/2012
Updated Immune Analysis From Phase 2 Clinical Trial Presented at 2012 Markers in Cancer Meeting
Number of cancer-related deaths going down
10/15/2012
There has recently been published a report in the journal, "Cancer," that shows death rates for Americans dying from malignancies continue to trend downward.
Abuja steps up war against tobacco smoking in public
10/15/2012
The administration said this at a Stakeholders Forum on the ban of smoking tobacco in public places, organized by the Social Development Secretariat of the FCT as part of strategy to consolidate and strengthen the campaign against cigarette smoking in public place in the Territory
Using cancer to fight cancer: The new vaccine
10/13/2012
Dr. David Avigan, Beth Israel Deaconess Medical Center, says "The goal of the vaccine is to see whether one can really re-educate our immune system to see cancer cells as foreign."
Immune Response Marker Connected to Prolonged Overall Survival
10/12/2012
Data presented at the Markers in Cancer Meeting, October 11, Hollywood, Fla., demonstrates that a specific tumor-reactive cytotoxic T cell (CTL) subset (CD28+/CCR7+/CD45RA- phenotype) displaying a broad Markers of Immune Function (MIFs) profile correlates with progression-free survival (PFS) and overall survival (OS) in patients treated with AGS-003.
Kidney Cancer Sucks Spin-A-Thon
10/12/2012
Teams of 3 to 5 riders are suggested, but individual riders are welcome. The registration fee for teams riding the full ten hours is a $250 donation to the Kidney Cancer Association. Individual rider registration is $25 per hour. All participants will receive âKidney Cancer Sucksâ orange T-shirts.
Kidney Cancer Research Announced
10/12/2012
Read about Argos Therapeutics Inc.'s ADAPT study and immunotherapy development, presented at our annual symposium in Chicago.
Who is the Criminal Mastermind Behind the Counterfeit Cancer Drug Scare?
10/12/2012
Seventy-six doctors in twenty-two states were contacted by the FDA because they may have purchased counterfeit Avastin from a "little-known drug wholesaler, Montana Healthcare Solutions," reported the Wall Street Journal.
The Kidney Walk Recycle for Life
10/11/2012
Another way to support kidney cancer research is by making a donation at http://kidneycancer.org.
News Feed